Biotech

All Articles

Novo inks $600M NanoVation bargain to analyze genetic medications ex-liver

.Novo Nordisk is actually proceeding its own press in to hereditary medications, agreeing to pay Nan...

Innovent hyperlinks cytokine to intestines cancer cells responses

.Innovent Biologics has created the instance that its own gate inhibitor-cytokine combination protei...

Merck, Daiichi ADC attacks target in phase 3 bronchi cancer cells study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens AI focus along with collab to pick cancer targets

.Five months after Rakovina Rehabs turned toward artificial intelligence, the cancer-focused biotech...

Ascendis' dwarfism medicine smash hits in phase 3, endangers BioMarin

.Ascendis Pharma has become a potential danger to BioMarin's Voxzogo, reporting stage 3 growth condi...

Despite ph. 3 skip, Alkeus sees road ahead of time for eye ailment possession

.Though Alkeus Pharmaceuticals' oral eye disease possession neglected to dramatically decrease geogr...

Kairos goes public along with $6M IPO to cash tests of cancer drug

.With a triad of biotechs striking the Nasdaq on Friday, it was quick and easy to overlook a smaller...

Vaccine as well as Keytruda combination effective in squamous cell carcinoma

.Immune system gate preventions are the superheroes of cancer therapy. Drugs like Bristol Myers Squi...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Regeneron's Opdualag opponent reveals 57% feedback fee

.Regeneron is back with lasting consequence for its own LAG-3 prevention and also PD-1 prevention co...